New fluid biomarkers tracking non-amyloid-β and non-tau pathology in Alzheimer’s disease

Cited by papers we hold 4

• Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease · 2022
  No notice
• Advances in the development of new biomarkers for Alzheimer’s disease · 2022
  No notice
• Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to Tau and Aß pathology · 2022
  No notice
• Neurotoxic Soluble Amyloid Oligomers Drive Alzheimer’s Pathogenesis and Represent a Clinically Validated Target for Slowing Disease Progression · 2021
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.